Agrawal A, Bhosale UA. A prospective pharmacovigilance study to evaluate adverse effect profile of first line anti-tubercular drugs in newly diagnosed sputum positive patients. Int J Basic Clin Pharmacol [Internet]. 2018 Jan. 23 [cited 2025 Oct. 23];7(2):283-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/2237